STAC3
Basic information
Region (hg38): 12:57243453-57251188
Links
Phenotypes
GenCC
Source:
- Bailey-Bloch congenital myopathy (Strong), mode of inheritance: AR
- Bailey-Bloch congenital myopathy (Supportive), mode of inheritance: AR
- Bailey-Bloch congenital myopathy (Moderate), mode of inheritance: AR
- Bailey-Bloch congenital myopathy (Definitive), mode of inheritance: AR
- Bailey-Bloch congenital myopathy (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Congenital myopathy 13 | AR | Musculoskeletal; Pharmacogenomic | Among other findings, individuals have been described with susceptibility to malignant hyperthermia related to anesthesia, and awareness may allow preventive measures | Craniofacial; Musculoskeletal | 23736855 |
ClinVar
This is a list of variants' phenotypes submitted to
- Bailey-Bloch_congenital_myopathy (230 variants)
- Inborn_genetic_diseases (41 variants)
- not_provided (37 variants)
- not_specified (11 variants)
- STAC3-related_disorder (6 variants)
- Congenital_myopathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STAC3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000145064.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 49 | 50 | ||||
| missense | 112 | 117 | ||||
| nonsense | 4 | |||||
| start loss | 0 | |||||
| frameshift | 8 | |||||
| splice donor/acceptor (+/-2bp) | 5 | |||||
| Total | 8 | 6 | 116 | 52 | 2 |
Highest pathogenic variant AF is 0.000064427644
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| STAC3 | protein_coding | protein_coding | ENST00000332782 | 11 | 7741 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.000172 | 0.994 | 125693 | 0 | 55 | 125748 | 0.000219 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.906 | 180 | 218 | 0.827 | 0.0000122 | 2405 |
| Missense in Polyphen | 76 | 84.692 | 0.89737 | 892 | ||
| Synonymous | 1.26 | 62 | 75.9 | 0.817 | 0.00000398 | 652 |
| Loss of Function | 2.44 | 10 | 22.5 | 0.445 | 0.00000122 | 256 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000814 | 0.000810 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000329 | 0.000326 |
| Finnish | 0.0000924 | 0.0000924 |
| European (Non-Finnish) | 0.000230 | 0.000229 |
| Middle Eastern | 0.000329 | 0.000326 |
| South Asian | 0.0000327 | 0.0000327 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Required for normal excitation-contraction coupling in skeletal muscle and for normal muscle contraction in response to membrane depolarization. Required for normal Ca(2+) release from the sarcplasmic reticulum, which ultimately leads to muscle contraction. Probably functions via its effects on muscle calcium channels (PubMed:23736855, PubMed:29078335). Increases CACNA1S channel activity, in addition to its role in enhancing the expression of CACNA1S at the cell membrane. Has a redundant role in promoting the expression of the calcium channel CACNA1S at the cell membrane (By similarity). Slows down the inactivation rate of the calcium channel CACNA1C (PubMed:29078335). {ECO:0000250|UniProtKB:Q8BZ71, ECO:0000269|PubMed:23736855, ECO:0000269|PubMed:29078335}.;
- Disease
- DISEASE: Native American myopathy (NAM) [MIM:255995]: A disease characterized by congenital weakness and arthrogryposis, cleft palate, ptosis, short stature, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia provoked by anesthesia. {ECO:0000269|PubMed:23736855, ECO:0000269|PubMed:29078335}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.420
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 43.57
Haploinsufficiency Scores
- pHI
- 0.162
- hipred
- Y
- hipred_score
- 0.524
- ghis
- 0.571
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.758
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Stac3
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; muscle phenotype;
Zebrafish Information Network
- Gene name
- stac3
- Affected structure
- fast muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- process quality
Gene ontology
- Biological process
- skeletal muscle contraction;neuromuscular synaptic transmission;intracellular signal transduction;skeletal muscle fiber development;positive regulation of voltage-gated calcium channel activity;positive regulation of protein localization to plasma membrane
- Cellular component
- nucleoplasm;cytosol;voltage-gated calcium channel complex;extrinsic component of cytoplasmic side of plasma membrane;sarcolemma
- Molecular function
- protein binding;identical protein binding;metal ion binding